TheraRadar
← Back
Data updated: Jul 17, 2026

RELIANT PHARMS

Pharma
Pharmaceuticals

RELIANT PHARMS is a pharmaceutical company with 1 FDA-approved products.

2007
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules

Upcoming FDA Decisions

Full Calendar →
Jan 20, 2027 — Foundayo (orforglipron)

RELIANT PHARMS's Key Drugs

RELIANT PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

RELIANT PHARMS's Recent FDA Approvals

New NDA/BLA approvals for RELIANT PHARMS over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

RELIANT PHARMS's Therapeutic Areas

Disease areas where RELIANT PHARMS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

RELIANT PHARMS Pipeline Snapshot

Active clinical trials for RELIANT PHARMS across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling